SuperworthJazz Pharmaceuticals shares outstanding JAZZ
Diluted shares outstanding, averaged over each quarter, from 2010.
- Latest quarter, to Jun 30, 2026
- 69.4M
- On a year earlier
- +13.4%
- more shares
Jazz Pharmaceuticals had 69.4M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 13.4% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 61.1M | −1% |
| FY2024 | 61.5M | −12% |
| FY2023 | 69.7M | +11% |
| FY2022 | 63.1M | +3% |
| FY2021 | 61.5M | +8% |
| FY2020 | 57.2M | −0% |
| FY2019 | 57.3M | −5% |
| FY2018 | 60.4M | −1% |
| FY2017 | 61.2M | +0% |
| FY2016 | 61M | −3% |
| FY2015 | 62.9M | −1% |
| FY2014 | 63.5M | +3% |
| FY2013 | 61.7M | +1% |
| FY2012 | 61.2M | +29% |
| FY2011 | 47.5M | +11% |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 69.4M | +13% | |
| Q1 FY26 | 66.1M | +8% | |
| Q4 FY25 | 61.1M | −1% | |
| Q3 FY25 | 61.6M | −2% | |
| Q2 FY25 | 61.2M | −12% | |
| Q1 FY25 | 61M | −2% | |
| Q4 FY24 | 61.5M | −12% | |
| Q3 FY24 | 63.2M | −11% | |
| Q2 FY24 | 69.6M | −5% | |
| Q1 FY24 | 62.5M | −15% | |
| Q4 FY23 | 69.7M | +11% | |
| Q3 FY23 | 71.3M | +14% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Jazz Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.